Discussion on gemcitabine combined with targeted drugs in the treatment of pancreatic cancer

被引：2
作者：
Huang, Jun-Hao [1 ]
Guo, Wei [1 ]
Liu, Zhe [1 ,2 ]
机构：
[1] China Med Univ, Hosp 1, Dept Pancreat Biliary Surg, Shenyang 110001, Liaoning, Peoples R China
[2] China Med Univ, Hosp 1, Dept Pancreat Biliary Surg, 155 Nanjing North St, Shenyang 110001, Liaoning, Peoples R China
来源：
WORLD JOURNAL OF GASTROENTEROLOGY | 2023年 / 29卷 / 03期
关键词：
Pancreatic cancer; Chemotherapy; Targeted therapy; Gemcitabine; Drug; Combination; SURVIVAL; THERAPY;
D O I：
10.3748/wjg.v29.i3.579
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Pancreatic cancer is a malignant tumor with poor prognosis. The treatment of pancreatic cancer depends on the tumor stage and type, and includes local treatment (surgery, radiotherapy and ablation intervention) and systemic therapy (chemotherapy, targeted therapy and immunotherapy). We read with great interest the review "Effective combinations of anti-cancer and targeted drugs for pancreatic cancer treatment" published on World J Gastroenterol and intended to share some of our perspectives in pancreatic cancer treatment. This review presents the therapeutic effects of the combination of gemcitabine and targeted drugs, which gives us a deeper insight into the combination treatments for pancreatic cancer.
引用
收藏
页码：579 / 581
页数：3
相关论文
共 50 条
[21]   Effective combinations of anti-cancer and targeted drugs for pancreatic cancer treatment [J].
Nishimoto, Arata .
WORLD JOURNAL OF GASTROENTEROLOGY, 2022, 28 (28) :3637-3643
[22]   Enhanced Antitumor Effect of Combined Gemcitabine and Proton Radiation in the Treatment of Pancreatic Cancer [J].
Galloway, Nicholas R. ;
Aspe, Jonathan R. ;
Sellers, Chelsey ;
Wall, Nathan R. .
PANCREAS, 2009, 38 (07) :782-790
[23]   Gemcitabine versus gemcitabine plus dalteparin thromboprophylaxis in pancreatic cancer [J].
Maraveyas, A. ;
Waters, J. ;
Roy, R. ;
Fyfe, D. ;
Propper, D. ;
Lofts, F. ;
Sgouros, J. ;
Gardiner, E. ;
Wedgwood, K. ;
Ettelaie, C. ;
Bozas, G. .
EUROPEAN JOURNAL OF CANCER, 2012, 48 (09) :1283-1292
[24]   Phase 1 trial of enzalutamide in combination with gemcitabine and nab-paclitaxel for the treatment of advanced pancreatic cancer [J].
Mahipal, Amit ;
Tella, Sri Harsha ;
Kommalapati, Anuhya ;
Goyal, Gaurav ;
Soares, Heloisa ;
Neuger, Anthony ;
Copolla, Domenico ;
Kim, Jongphil ;
Kim, Richard .
INVESTIGATIONAL NEW DRUGS, 2019, 37 (03) :473-481
[25]   Harmine suppresses the proliferation of pancreatic cancer cells and sensitizes pancreatic cancer to gemcitabine treatment [J].
Wu, Lin-Wen ;
Zhang, Jian-Kang ;
Rao, Mingjun ;
Zhang, Zuo-Yan ;
Zhu, Hua-Jian ;
Zhang, Chong .
ONCOTARGETS AND THERAPY, 2019, 12 :4585-4593
[26]   Gemcitabine: Progress in the treatment of pancreatic cancer [J].
Heinemann, V .
ONCOLOGY, 2001, 60 (01) :8-18
[27]   Emerging drugs for the treatment of pancreatic cancer [J].
Van Laethem, Jean-Luc ;
Marechal, Raphael .
EXPERT OPINION ON EMERGING DRUGS, 2007, 12 (02) :301-311
[28]   Combined Efficacy of Nimotuzumab and Gemcitabine on the Treatment of Advanced Pancreatic cancer [J].
Li, Yi ;
Li, Dan ;
Liu, Qianqian ;
Li, Jun .
PANCREAS, 2024, 53 (06) :e537-e542
[29]   Gemcitabine and pancreatic cancer [J].
Prost, P ;
Ychou, M ;
Azria, D .
BULLETIN DU CANCER, 2002, 89 :S91-S95
[30]   Gemcitabine Combined With Uracil-Tegafur in Patients With Advanced Pancreatic Cancer [J].
Coskun, Ugur ;
Alkis, Necati ;
Celenkoglu, Gokhan ;
Buyukberber, Sueleyman ;
Ozkan, Metin ;
Camci, Celalettin ;
Uner, Aytug ;
Er, Ozlem ;
Aslan, Ulkue Yalcintas ;
Sevinc, Alper ;
Tokluoglu, Saadet ;
Ozturk, Banu ;
Yildiz, Ramazan ;
Benekli, Mustafa .
JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, 2009, 101 (08) :761-764
12345